[SYRE] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Dec-2016
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 12.10%
YoY- -37.52%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 1,261 1,479 982 1,247 1,149 1,373 859 29.13%
PBT -7,874 -6,632 -6,247 -5,483 -6,238 -5,430 -4,547 44.15%
Tax 0 0 0 0 0 0 0 -
NP -7,874 -6,632 -6,247 -5,483 -6,238 -5,430 -4,547 44.15%
Tax Rate - - - - - - - -
Total Cost 9,135 8,111 7,229 6,730 7,387 6,803 5,406 41.82%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -624.43 -448.41 -636.15 -439.70 -542.91 -395.48 -529.34 11.63%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -12.00 -11.75 -11.68 0.00 -11.70 -11.53 -9.95 13.28%
EPS Diluted -12.00 -11.75 -11.68 0.00 -11.70 -11.53 -9.95 13.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.